Knocking out Tox in CD8+ CAR tumor infiltrating lymphocytes (TILs) increase cytolytic activity further supporting the notion that TOX specifically attenuates CD8+ T cell effector function (Figure 1). The gene discussed is CD8A; the disease is neoplasm.